Cabinet Expert Scientifique et Réglementaire
Cabinet Expert Scientifique et Réglementaire
COVID-19 has been recognized as pandemic by the world health organization (WHO) since March 11, 2020. COVID-19 causes inflammation in the lung tissue, which is usually accompanied by symptoms such as dry cough, chest pain, fever, and difficulty breathing. Simultaneously …
This randomized, controlled, open-label, single-center trial was conducted on 124 patients with COVID-19 receiving either 0, 400 or 800 mg/day EPP-AF® brazilian green propolis for 28 days. All participants received standard care including all necessary interventions, as determined by physician. …
This double-blind, randomized and controlled trial aimed to determine the effects of curcumin administered with piperine (to optimize absorption) on symptoms of patients with COVID-19 in addition to conventional treatment. Subjects received curcumin (525 mg) with piperine (2.5 mg) in …
This 28-day randomized, double-blind and controlled trial aimed to determine whether virgin coconut oil (VCO) could be used as an adjunct prophylaxis to prevent the progression of symptoms among suspect or probable cases of COVID-19 (n = 63 adults) in …
Food supplements can be included in the various approaches for the management of COVID-19 infections. However, evidences are scarce, and this study investigated the potential preventive effects of food supplements on COVID-19 infections. 445850 subscribers of an app aiming to …
Nutritional supplements, TaibUVID (each dose contained 2g nigella sativa, 1g chamomile and 10 ml natural honey) and TaibUVID Forte (adds 1g fennel, 0.5 gram costus, 0.5 gram senna to TaibUVID), were suggested as a adjuvants for COVID-19 contacts, patients and …
This pilot study, double-blinded, placebo-controlled and randomized, examined the prophylactic effect of neem in patients at risk of COVID-19 infection due to contact with COVID-19 positive patients. 190 participants have been enrolled. They received a placebo or 50 mg twice …
In this double-blind, randomized clinical trial, 128 critically ill patients (35-85 years) infected with COVID-19 have been randomly assigned to the intervention (fortified formula with omega 3 fatty acids) (n = 42) and control (n = 86) groups during 14 …
Researchers continue to examine the potential effectiveness of botanicals and their active compounds for the management of CODIV-19 infection. Recently, two studies have provided data on the potential efficacy of two well-known compounds. Park et al. (2021) have published an …
A preprint article reports that melatonin exposure after intubation in patients with positive diagnosis to COVID-19 is statistically associated with a positive outcomes (Ramlall et al., 2020). Following these results, another recent article tried to summarize the potential effect of …